Skip to main content
. 2015 Sep;354(3):328–339. doi: 10.1124/jpet.115.225326

TABLE 3.

Potencies for substitution in Δ9-THC discrimination

ED50 (±95% CIs) are expressed in μmol/kg. Molecular weights are provided in parentheses. All compounds were administered intraperitoneally.

Compound CB1 Ki ED50
nM μmol/kg
THC DD (lever)
 Δ9-THC (n = 7) 41a 4.5
 (314) (2) (3.5–5.7)
 JWH-018 (n = 11) 9.5a 0.35
 (341) (4.5) (0.32–0.50)
 CP47,947 (n = 8) 9.5b 0.85
 (318) (0.35) (0.47–1.45)
 WIN 55,212-2 (n = 3) 1.9a 0.80
 (522) (0.1) (0.46–1.38)
THC DD (nose poke)
 Δ9-THC (n = 20) 41a 5.7
 (314) (2) (4.8–6.7)
 AB-CHMINACA (n = 8) 0.78 0.34
 (356) (0.11) (0.22–0.50)
 AB-PINACA (n = 9) 2.87 3.78
 (330) (0.69) (2.42–5.87)
 FUBIMINA (n = 6) 296.1 131
 (360) (33.5) (72–233)

DD, drug discrimination.

a

Showalter et al., 1996.